RBC’s top 10 questions and answers on biotech stocks By Investing.com

Investing.com — In a recent note to clients, RBC Capital Markets has outlined the top 10 questions investors are posing about the biotechnology sector, providing insights into the key issues driving market sentiment. 1) Among the most prominent inquiries is how the new Trump-led administration could impact the FDA. Investors are particularly curious about the role RFK Jr. might play if he were to hold a position in federal healthcare

Read More

Deadly Zhuhai car attack sparks questions in China

A car attack that killed 35 people in China has sparked questions about a recent spate of public violence, as officials continue to censor discussion on the incident. On social media, many are discussing the social phenomenon of “taking revenge on society”, where individuals act on personal grievances by attacking strangers. Police said the driver who ploughed into crowds at a stadium in the southern city of Zhuhai on Monday

Read More

Questions about AIMCo’s future? Join our Q&A

Article content The Alberta government surprised everyone by firing the chief executive and entire board of directors at Alberta Investment Management Co. (AIMCo) last week, declaring the need for a “reset” at the $160-billion asset manager. What does this mean for the future of AIMCo, Alberta Premier Danielle Smith‘s Alberta Pension Plan gambit and the province’s Heritage Fund? We want to answer your questions. Please join the Calgary Herald’s Chris

Read More